10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Innovative therapies and drug discovery are pivotal in addressing the growing challenges posed by infectious diseases. Traditional treatment methods are often limited, and emerging pathogens or drug resistance necessitate the development of new approaches. In the field of innovative therapies and drug discovery, cutting-edge technologies such as gene editing, monoclonal antibodies, and novel antiviral agents are being explored to provide more effective treatments. The advent of personalized medicine also allows for the development of targeted therapies that can be tailored to individual patients, optimizing outcomes. With advances in drug screening, computational modeling, and high-throughput testing, the process of discovering new drugs is becoming faster and more efficient, offering hope for combatting both old and new infectious threats.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : An unprecedented West Nile virus outbreak in Israel (2024): A textbook case for the One Health approach
Michel Bellaiche, Kimron Veterinary Institute, Israel
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, IDFISH Technology, United States
Title : Candida auris infections are global health challenge
Reza Nassiri, Michigan State University, United States
Title : Host brakes on viral inflammation
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States